Study to Evaluate the Efficacy and Safety of JP-1366 in the Prevention of NSAIDs-Induced Peptic Ulcers
Clinical trial NCT06439563 · RECRUITING
Trial details
- NCT number
- NCT06439563
- Sponsor
- Onconic Therapeutics Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-22
- Primary completion
- 2027-08-01
- Enrollment
- 364
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.